Public Pharma For Europe https://validator.w3.org/feed/docs/rss2.html Knowledge Hub Home Big pharma is at war with the UK, and the government can’t back down now La política del medicamento en la UE y su renuncia a la salud global Greed Is a Hell of a Drug The pandemic accord: new possibilities for public health industrialisation pathways? Big Pharma is using tariffs to hold Europe to ransom Romania vrea sa-si faca medicamentele acasa | Moment strategic pentru industria farmaceutica New $55 Insulin Pens Mark Step in California’s Fight Against Insulin Price Gouging ‘It’s horrible telling customers their medicine isn’t available’ The UK must defend drug price controls Transforming trade for vaccine equity: Policy gaps and barriers Translating Pasteur’s Vision in Eastern Europe Resurgence: Patently Ill-Served: Patent protections are pushing medicines out of patients’ reach The European Pharmaceutical Package Agreement: an insufficient step that preserves industry privileges and fails to guarantee equitable access to medicines Directive eaux usées : chronique d’un lobbying à retardement World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML All-Party ParliamentaryGroup on Pharmacy The Empty Medicine Cabinet: Urgent Action Needed to Resolve TB Drug Shortages in Europe US drug pricing shake-up threatens access to medicines in Europe Pharma lobbyists cash in on Brussels red tape rampage Farmacêuticas Públicas: Um Remédio para as Falhas no Abastecimento de Medicamentos Bridging the Gap: securing access to essential TB medicines in the EU and EEA Reclaiming drug discovery: why we need public pharma Farmacêuticas públicas: antídoto ao desabastecimento Public Pharma— Ein Gegenmittel bei Arzneimittelengpässe Findings from T1International’s 2024 Out-of-Pocket Expenses and Rationing Survey Public Pharma: A Remedy for Drug Shortages Drug Dealing: Making Public Pharma Work About Us FINALLY, THE PANDEMIC AGREEMENT!!! …… Many missed opportunities, but a beginning made Private finance and the threat to global health ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers Late disclosures of federal funding in US patents  Open drug pricing activist MSF signs secrecy pacts with Big Pharma Access to oncology medicines in EU and OECD countries Universal Health Coverage at a crossroads: reclaiming the right to health from market logic Free trade agreement with Malaysia: Switzerland imperils the rights to food and health Sweden’s new antibiotic factory could serve as EU and NATO strategic asset If Not Now, Then When? Reimagining Global Health Equity Making Access to Quality Healthcare a Top Priority for the EU Against the normalization of limited access to CAR-T cell therapies Para confrontar a Big Pharma, Farmacêuticas Públicas Knowledge Hub Fearing Trump cuts, California Democrat proposes creating state’s own NIH Informational flyer about the PPfE coalition Leven van Erik (55) uit Oosterhesselen gered door experimenteel medicijn UMCG. ‘Kritiek farmalobby tenenkrommend’ Shortage of antiseizure medication in Germany: How big is the problem? EAHP 2023 Shortage Survey Report What Stands in the Way of Abundance in Healthcare?